Every 40 seconds, someone in the United States has a stroke. When a blood clot blocks an artery in the brain, every minute matters. But physicians performing clot-removal procedures face a significant challenge: they can't always see exactly where the clot begins.
Perceptive Robotics is developing technology that could help change that.
In this episode of The Hatch Podcast, Tim Scott talks with Evan Austill, co-founder and Chief Development Officer of Perceptive Robotics, a Vanderbilt University spinout developing a new approach to stroke treatment.
The company's first product, LumenSense, is designed to give physicians a sense of touch during catheter-based procedures. The small device attaches to existing aspiration catheters, helping physicians determine when the catheter tip has reached a blood clot without requiring changes to the equipment or procedure they're already using.
Evan shares how eight years of Vanderbilt research led to the company, the progress they've made through preclinical testing, and what lies ahead as they work toward FDA clearance. He also discusses his experience building medical technology companies, the challenges of bringing new devices to market, and how Hatch's Powered by Bessel accelerator is helping connect Perceptive Robotics with the broader medical technology community.
In this episode:
Featured in This Episode
Evan Austill Jr.
Co-Founder & Chief Development Officer
Perceptive Robotics
Learn More:
Perceptive Robotics
https://perceptiverobotics.ai
Evan Austill on LinkedIn
https://www.linkedin.com/in/evanaustill/
About Hatch:
Hatch Fairhope
https://hatchfairhope.com
Produced by Tim Scott
in/timscottproductions